Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Blasczyk

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
Frontiers in Bioengineering and Biotechnology|April 28, 2022
Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell TherapyAgnes Bonifacius, Sabine Tischer-Zimmermann, Maria Michela Santamorena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 16, 2021
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 VaccinationMetodi V Stankov, Anne Cossmann, Agnes Bonifacius, et al.
Journal of Virology|November 4, 2024
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutationSaskia C Stein, Guido Hansen, George Ssebyatika, et al.
Immunity|February 10, 2021
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responsesAgnes Bonifacius, Sabine Tischer-Zimmermann, Anna C Dragon, et al.
Molecular Therapy. Methods & Clinical Development|June 7, 2021
Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvLJulia K Bialek-Waldmann, Sabine Domning, Ruth Esser, et al.
Mbio|July 31, 2025
A critical residue in a conserved RBD epitope determines neutralization breadth of pan-sarbecovirus antibodies with recurring YYDRxxG motifsSaskia C Stein, George Ssebyatika, Tim Benecke, et al.
Frontiers in Immunology|November 21, 2022
Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19Martijn Zoodsma, Aline H de Nooijer, Inge Grondman, et al.
The Journal of Clinical Investigation|May 9, 2023
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsAgnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, et al.
The Journal of Clinical Investigation|November 3, 2022
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patientsSixten Körper, Beate Grüner, Daniel Zickler, et al.
Communications Biology|January 5, 2024
Human leukocyte antigen-DQA1*04:01 and rs2040406 variants are associated with elevated risk of childhood Burkitt lymphomaZhiwei Liu, Yang Luo, Samuel Kirimunda, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
Frontiers in Bioengineering and Biotechnology|April 28, 2022
Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell TherapyAgnes Bonifacius, Sabine Tischer-Zimmermann, Maria Michela Santamorena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 16, 2021
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 VaccinationMetodi V Stankov, Anne Cossmann, Agnes Bonifacius, et al.
Journal of Virology|November 4, 2024
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutationSaskia C Stein, Guido Hansen, George Ssebyatika, et al.
Immunity|February 10, 2021
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responsesAgnes Bonifacius, Sabine Tischer-Zimmermann, Anna C Dragon, et al.
Molecular Therapy. Methods & Clinical Development|June 7, 2021
Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvLJulia K Bialek-Waldmann, Sabine Domning, Ruth Esser, et al.
Mbio|July 31, 2025
A critical residue in a conserved RBD epitope determines neutralization breadth of pan-sarbecovirus antibodies with recurring YYDRxxG motifsSaskia C Stein, George Ssebyatika, Tim Benecke, et al.
Frontiers in Immunology|November 21, 2022
Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19Martijn Zoodsma, Aline H de Nooijer, Inge Grondman, et al.
The Journal of Clinical Investigation|May 9, 2023
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsAgnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, et al.
The Journal of Clinical Investigation|November 3, 2022
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patientsSixten Körper, Beate Grüner, Daniel Zickler, et al.
Communications Biology|January 5, 2024
Human leukocyte antigen-DQA1*04:01 and rs2040406 variants are associated with elevated risk of childhood Burkitt lymphomaZhiwei Liu, Yang Luo, Samuel Kirimunda, et al.
Pageof 21